PR & Press Release Distribution
NewswireJet
NewswireJet booked 15 to 20 qualified client meetings a day with BrandJet
20k emails a day plus LinkedIn on 5 accounts. 15 to 20 meetings booked daily.
Loading...
A multi-channel outbound engine connecting an FDA-cleared cardiac monitoring platform with the clinicians who prescribe it.
Client snapshot
Headline result
Meetings booked with cardiology practices
Selling into cardiology means earning time with busy clinicians and practice administrators, and BrandJet consistently put us in those rooms. The meetings were with the right practices, the context was always relevant, and the engine kept running while our team focused on the clinical conversations that close.
The client
Wearlinq is a San Francisco based medtech company behind eWave, the first wireless, continuous, FDA-cleared 6-lead ECG multimodal monitor. Paired with the LiveLinq full-disclosure platform, a patient mobile app, and rapid STAT reporting, Wearlinq gives cardiologists a multidimensional view of the heart while keeping patients comfortable and compliant.
The company acquired AMI Cardiac Monitoring in 2024 to expand clinical services nationwide and closed a $14M Series A led by AIX Ventures in December 2025. Wearlinq is led by co-founder and CEO Konrad Morzkowski.
The challenge
Wearlinq had a clinically differentiated product and FDA clearance, but adoption runs through a hard-to-reach buyer: cardiologists, electrophysiologists, and the practice administrators who decide which ambulatory monitoring service their clinic prescribes. These buyers are time-poor, gatekept, and loyal to incumbent monitoring providers.
Wearlinq needed a repeatable way to open conversations with cardiology practices and clinics across the United States, consistently enough to feed its commercial team with qualified meetings rather than relying on conferences and referrals alone.
Our solution
We built and operated a two-channel outbound system for Wearlinq on BrandJet, purpose-built for the realities of selling into clinical practices.
A tightly scoped universe of US cardiology practices and clinics prescribing ambulatory cardiac monitoring, segmented by practice size, monitoring volume signals, and incumbent provider fit.
Cardiologists and electrophysiologists for clinical credibility, practice managers and administrators for the operational decision, each with messaging matched to what they care about.
Direct, non-promotional copy anchored on what differentiates eWave: 6-lead diagnostic clarity, wireless continuous wear, patient compliance, and STAT report turnaround, written to respect a clinical reader's time.
A connection-and-message motion reaching administrators and clinicians active on the platform, reinforcing the email touchpoints with a human presence.
Replies were qualified on prescribing fit and monitoring volume before booking, so the meetings reaching Wearlinq's commercial team were with practices genuinely able to adopt.
Client outcomes
Wearlinq gained a predictable outbound channel into a market that traditionally runs on conferences, referrals, and field reps. The engine put its commercial team in front of prescribing practices and hospital decision-makers on a steady cadence, complementing the company's nationwide clinical expansion following the AMI Cardiac Monitoring acquisition.
The engagement is ongoing, and we continue to open doors into cardiology practices for Wearlinq's team to convert.
The engine delivered a consistent flow of qualified clinical conversations:
Outcome highlights
A qualified meeting is defined as a booked call with a practice that prescribes ambulatory cardiac monitoring and expressed interest in evaluating eWave.